Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Gabrielle Tergemina Clain"'
Autor:
Cécile Charles, Mahasti Saghatchian, Philippe Amiel, Sarah Dauchy, Benjamin Lacas, Suzette Delaloge, Ines Vaz-Luis, Diane Boinon, Amal Ghouadni, Gabrielle Tergemina Clain
Publikováno v:
Quality of Life Research. 31:723-732
Beauty care (BTC) is offered at many cancer hospitals having a great uptake among patients. Nevertheless, its benefits in the Quality of life (QoL) of cancer survivors have not been assessed so far. Our study aims to determine whether BTC improves pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0fdfaef05374fb3808a9d82a4473001
https://doi.org/10.1007/s11136-021-02947-6
https://doi.org/10.1007/s11136-021-02947-6
Autor:
Emmanuelle Kempf, Nathalie Lemoine, Gabrielle Tergemina-Clain, Anthony Turpin, Sophie Postel-Vinay, Emilie Lanoy, Jean-Charles Soria, Christophe Massard, Antoine Hollebecque
Publikováno v:
PLoS ONE, Vol 11, Iss 5, p e0154895 (2016)
INTRODUCTION:Enrolling cancer patients in phase I clinical trials (P1s) requires that they fulfill specific criteria. Between the time they sign the consent form and the 1st administration of the experimental drug, some patients may be excluded and c
Externí odkaz:
https://doaj.org/article/684a3b35378046bcab3eeb39ead16f76
Autor:
Mahasti, Saghatchian, Benjamin, Lacas, Cécile, Charles, Amal, Ghouadni, Gabrielle Tergemina, Clain, Diane, Boinon, Suzette, Delaloge, Ines, Vaz-Luis, Sarah, Dauchy, Philippe, Amiel
Publikováno v:
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 31(3)
Beauty care (BTC) is offered at many cancer hospitals having a great uptake among patients. Nevertheless, its benefits in the Quality of life (QoL) of cancer survivors have not been assessed so far.Our study aims to determine whether BTC improves pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2143f58692e4d59acf83118e6a35fa91
https://pubmed.ncbi.nlm.nih.gov/34324138
https://pubmed.ncbi.nlm.nih.gov/34324138
Autor:
Pernelle Lavaud, Etienne Suc, Gwenaelle Gravis, Alain Ravaud, Gael Deplanque, Igor Latorzeff, Florence Joly, Nicole Tubiana-Mathieu, Muriel Habibian, Jean-Marie Boher, Brigitte Laguerre, Christian Platini, Stéphane Oudard, Jean Marc Ferrero, Jean-François Berdah, Stéphane Culine, Frederic Rolland, Frank Priou, Clemence Legoupil, Damien Pouessel, Ivan Krakowski, Philippe Beuzeboc, Ali Hasbini, Jérôme Dauba, Jean-Christophe Eymard, Claude El Kouri, Marjorie Baciuchka, Stéphanie Foulon, Remy Delva, Loic Mourey, Michel Soulié, Claude Linassier, Guilhem Bousquet, Christine Theodore, Sylvie Zanetta, Gabrielle Tergemina-Clain, Karim Fizazi, Jean-Pascal Machiels
Publikováno v:
European Urology
European Urology, 2017, ⟨10.1016/j.eururo.2017.09.022⟩
European Urology, 2017, ⟨10.1016/j.eururo.2017.09.022⟩
Background Androgen deprivation therapy (ADT) plus docetaxel is the standard of care in fit men with metastatic castration-naive prostate cancer (mCNPC) following results from GETUG-AFU 15, CHAARTED, and STAMPEDE. No data are available on the efficac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1040aebf886696a2b0d18501c3ffa7fe
https://doi.org/10.1016/j.eururo.2017.09.022
https://doi.org/10.1016/j.eururo.2017.09.022
Autor:
Benjamin Besse, Gabrielle Tergemina-Clain, Laura Faivre, Jordi Remon, Francesco Facchinetti, David Planchard, Jean-Pierre Pignon, Jean-Charles Soria, Ludovic Lacroix, Maria Bluthgen
Publikováno v:
Lung Cancer. 112:62-68
Background LKB1/STK11 ( STK11 ) is among the most inactivated tumor-suppressor genes in non-small cell lung cancer (NSCLC). While evidence concerning the biologic role of STK11 is accumulating, its prognostic significance in advanced NSCLC has not be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc692bd258ce64f9f2d87f0ce9aa3bca
https://doi.org/10.1016/j.lungcan.2017.08.002
https://doi.org/10.1016/j.lungcan.2017.08.002
A Case-Control Study Brings to Light the Causes of Screen Failures in Phase 1 Cancer Clinical Trials
Autor:
Emilie Lanoy, Sophie Postel-Vinay, Christophe Massard, Anthony Turpin, Gabrielle Tergemina-Clain, Emmanuelle Kempf, Nathalie Lemoine, Jean-Charles Soria, Antoine Hollebecque
Publikováno v:
PLoS ONE
PLoS ONE, Vol 11, Iss 5, p e0154895 (2016)
PLoS ONE, Vol 11, Iss 5, p e0154895 (2016)
INTRODUCTION:Enrolling cancer patients in phase I clinical trials (P1s) requires that they fulfill specific criteria. Between the time they sign the consent form and the 1st administration of the experimental drug, some patients may be excluded and c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50943938531fec8a7b59a0d2ca60f4ac
http://europepmc.org/articles/PMC4858154
http://europepmc.org/articles/PMC4858154
Autor:
B. Laguerre, Muriel Habibian, G. Gravis, Florence Joly, Gabrielle Tergemina-Clain, Karim Fizazi, Michel Soulié, Pernelle Lavaud, Igor Latorzeff, Stéphanie Foulon, J-M Ferrero, Jean-Marie Boher, Remy Delva, Clemence Legoupil, Loic Mourey, Stéphane Oudard, P. Beuzeboc, Frank Priou, Christine Theodore, Ivan Krakowski
Publikováno v:
Annals of Oncology. 27:vi259
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29c0b00ab531ae4daddad624cd804a94
https://doi.org/10.1093/annonc/mdw372.45
https://doi.org/10.1093/annonc/mdw372.45
Autor:
Ludovic Lacroix, Laura Faivre, Jean-Pierre Pignon, Jean-Charles Soria, Francesco Facchinetti, David Planchard, Benjamin Besse, Gabrielle Tergemina Clain, Maria Bluthgen
Publikováno v:
Cancer Research. 76:2250-2250
Background: STK11 (also called LKB1) is among the 3 most mutated genes in lung adenocarcinoma, but its prognostic and predictive significance in advanced NSCLC patients is still not clear. Recent preclinical and translational evidence suggest its rol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c05706a86bcb7668d6e0d9a4733a4a6f
https://doi.org/10.1158/1538-7445.am2016-2250
https://doi.org/10.1158/1538-7445.am2016-2250
Autor:
Pernelle Lavaud, Michel Soulié, Brigitte Laguerre, Christine Theodore, Clemence Legoupil, Karim Fizazi, Stéphanie Foulon, Muriel Habibian, Igor Latorzeff, Franck Priou, Jean Marie Boher, Remy Delva, Gabrielle Tergemina-Clain, Loic Mourey, Florence Joly, Jean Marc Ferrero, Gwenaelle Gravis, Ivan Krakowski, Stéphane Oudard, Philippe Beuzeboc
Publikováno v:
Journal of Clinical Oncology. 34:5080-5080
5080Background: Since 2015, docetaxel chemotherapy, combined with ADT, is considered the standard of care in fit men with metastatic hormone-naive prostate cancer (m-HNPC), based on data from three...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be80b4399311a054b2bfc13f74d6253a
https://doi.org/10.1200/jco.2016.34.15_suppl.5080
https://doi.org/10.1200/jco.2016.34.15_suppl.5080
Autor:
Eric Dupont-Bierre, Guillaume Passot, Gabrielle Tergemina-Clain, David Malka, Rosine Guimbaud, Benjamin Lacas, Michel Ducreux, Jean-Pierre Pignon, Olivier Glehen, Denis Smith, Valérie Boige
Publikováno v:
Journal of Clinical Oncology. 34:e15003-e15003
e15003Background: IAHCT is more and more recognized in the management of LMCRC. Regarding its anti-angiogenic effect bevacizumab (B) could be considered as a good candidate for IAH treatment. This ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::199f6631a1a64a1f8450f647f70481f9
https://doi.org/10.1200/jco.2016.34.15_suppl.e15003
https://doi.org/10.1200/jco.2016.34.15_suppl.e15003